Epidemiology


Etiology


  • Pathogen: Nocardia species (ubiquitous in soil worldwide)
    • Reservoir: soil
    • Gram positive with branching filaments
    • Aerobe
    • Weakly acid-fast staining (Ziehl-Neelsen stain) c
    • Catalase positive
  • Risk factors

Pathophysiology


Clinical features


Pulmonary nocardiosis

  • Risk group: immunocompromised individuals
  • Clinical features
    • Constitutional: fever, weight loss, anorexia, night sweats
    • Respiratory (recurrent pneumonia): productive cough, dyspnea, pleuritic chest pain
    • Pulmonary nocardiosis symptoms such as fever, chills, and weight loss are often mistaken for tuberculosis

Diagnostics


Treatment

  • First-line Tx:
    • TMP-SMX high-dose (15-20 mg/kg/day of TMP component, IV or PO depending on severity). c
  • Severe, Disseminated, or CNS Disease:
    • Combination therapy: TMP-SMX + Amikacin AND/OR a Carbapenem (e.g., Imipenem or Meropenem).
  • Duration of Therapy:
    • Cutaneous: 3 months.
    • Pulmonary: At least 6 months (immunocompetent).
    • Immunocompromised or CNS disease: At least 12 months to prevent relapse.
  • Surgical Management:
    • Drainage/resection of large empyemas or brain abscesses not responding to medical Tx.